Drug intelligence / Profile preview

picrorhiza kurroa

Development stage
Unknown
Lead developer
Sabinsa
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Picrorhiza kurroa** (also known as "Kutki") is a perennial herb native to the Himalayan region, valued in Ayurvedic medicine for its bitter rhizomes used primarily as a hepatoprotective agent. Its key active constituents, kutkin (a mixture of picroside I, picroside II, kutkoside, and other iridoid glycosides), exhibit liver-protective effects by reducing elevated liver enzymes (SGOT, SGPT), promoting hepatic regeneration, and protecting against toxins like acetaminophen, galactosamine, and viruses such as hepatitis B and C. It demonstrates anti-inflammatory activity via NF-κB modulation, antioxidant properties, immunomodulation by enhancing cytokine production (IFN-γ, IL-4), antibacterial effects against Gram-positive and Gram-negative bacteria, anticancer cytotoxicity in cell lines (breast, liver, prostate), antidiabetic effects by lowering blood glucose and improving GLUT-4 translocation, and additional benefits in asthma, vitiligo, and skin disorders. Clinical trials support its use in acute viral hepatitis, NAFLD, NASH, and vitiligo, typically at 300-500 mg doses of rhizome powder 2-3 times daily, with a favorable safety profile from traditional use though mild GI side effects like diarrhea can occur.[1][2][3][4][5]

Other names
kutkikutakikarkatika
02

Targets

NF-κBCYP3A4 (Cytochrome P450 3A4)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on picrorhiza kurroa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on picrorhiza kurroa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call